002099.SZ Stock Analysis
00
Uncovered
Zhejiang Hisoar Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the production of active pharmaceutical ingredients and fine chemicals. The company is headquartered in Taizhou, Zhejiang and currently employs 2,899 full-time employees. The company went IPO on 2006-12-26. is a China-based company principally engaged in the manufacture and sale of pharmaceutical materials and dyes. The firm operates through two segments: Pharmaceutical segment and Dye segment. Pharmaceutical segment manufactures and sells Active Pharmaceutical Ingredients (APIs) and preparations, as well as provides customized production and supporting research and development services for international pharmaceutical companies. The Company’s pharmaceutical products comprise antibiotic series, hypoglycemic series and cardiovascular series. Dye segment is mainly involved in the manufacture and sale of environmentally friendly reactive dyes, dye intermediates and pigment intermediates. The firm distributes its products within domestic market and to overseas markets.